Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies

Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies

From RCT to mechanistic study: ATRA reverses myofibroblast activation by reprogramming glucose metabolism via HIC1 and PCK1/2 to attenuate hypertrophic scar formation

Frostbite: diagnosis, treatment, prognosis, and future directions

Engineered exosomes for diabetic foot ulcers: lessons learned, challenges remain

Department of Pathophysiology, School of Medicine, Nantong University

Department of Critical Care, Affiliated Hospital of Nantong University

Department of Pathology, the First Hospital of Lanzhou University

Institute of Cancer Neuroscience, Medical Frontier Innovation Research Center, the First Hospital of Lanzhou University, the First Clinical Medical College of Lanzhou University

State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Tianjin Key Laboratory of Gene Therapy for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College